SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-043051
Filing Date
2022-11-25
Accepted
2022-11-23 17:35:31
Documents
12
Period of Report
2022-11-18
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K brhc10044678_8k.htm   iXBRL 8-K 28628
  Complete submission text file 0001140361-22-043051.txt   163030

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA advm-20221118.xsd EX-101.SCH 3863
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE advm-20221118_lab.xml EX-101.LAB 22547
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE advm-20221118_pre.xml EX-101.PRE 16043
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc10044678_8k_htm.xml XML 4043
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 221417234
SIC: 2836 Biological Products, (No Diagnostic Substances)